Sashi S. Kommu

FEBU FRCS (Urol)

Dr Sashi S. Kommu is an Associate Professor in Uro-oncology and Cancer Biology in The School of Biosciences; The University of Kent, United Kingdom. He is also a Consultant Pelvic Cancer Urological Surgeon with a subspecialty interest in minimally invasive management of urological cancers including laparoscopic and robotic urological surgery at East Kent Hospitals University NHS Foundation Trust. He leads The National Institute for Health Research (NIHR) for all surgical specialties for Kent, Surrey and Sussex in the U.K. His key clinical interests are in the minimally invasive management of urological cancers, surgical robotics and intelligent probes. He has done formal research at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research with The Translational Cancer Genetics Team where he refined his scientific methodology in advanced laboratory work with an emphasis on cancer genetics and proteomics. He has also gained vast exposure in nanotechnology. He has over 100 peer-reviewed publications in respected scientific and medical journals including The Lancet. He also has over 300 scientific presentations, several book chapters and books. Dr Kommu has over 25 academic awards including The Olympus Award at The 25th World Congress of Endourology in Cleveland U.S.A. 2006. He has nine pending patents including a cost-effective Telerounding Kit for Remote Teleconsultations, which was presented at The House of Commons (Hosted by The British Parliament) in 2006. His ability to blend medical science with engineering and technology has earned him two NASA collaborative scientific commendations. Dr Kommu is reviewer for 15 surgical/urological and 3 basic sciences journals. Several novel concepts described by Dr Kommu include ‘suppressor screening in urological cancer screening’ and ‘the supplementary biomarker approach’ for detecting cancers.

2books edited

1chapters authored

Latest work with IntechOpen by Sashi S. Kommu

Urology is currently the most rapidly expanding surgical superspecialty. The reason for this exponential propulsion of this field, especially over the last two decades, is the dual role of scientific breakthroughs and the successful coupling of engineering and technology for diagnostics and treatment. The role of minimally invasive approaches to surgical extirpation and reconstruction has been unprecedented and paramount. Not only is there rapid development within each substrata of urology but these developments are continuously evolving. This book is the first in a series that explores the current evolving trends in urology. The focus of the book is broad and includes strata of the field including stone disease, telerobotic surgery and surgical simulation. The role of internet based "Apps" are also explored. Some chapters explore leading edge concepts while others capture the evolving trends and future concepts.

Go to the book